d'Esparbes Eric's most recent trade in Biora Therapeutics Inc was a trade of 27,830 Common Stock done at an average price of $0.7 . Disclosure was reported to the exchange on Aug. 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biora Therapeutics Inc | Eric d'Esparbes | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. | 15 Aug 2024 | 27,830 | 575,832 | - | 0.7 | 18,646 | Common Stock |
| Biora Therapeutics Inc | d'Esparbes Eric | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 325,000 | 603,662 | - | 0 | Common Stock | |
| Biora Therapeutics Inc | Eric d'Esparbes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 219,650 | 278,662 | - | 0 | Common Stock | |
| Biora Therapeutics Inc | Eric d'Esparbes | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.14 per share. | 15 Aug 2023 | 40,022 | 59,012 | - | 3.1 | 125,669 | Common Stock |
| Biora Therapeutics Inc | Eric d'Esparbes | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.35 per share. | 15 May 2023 | 2,807 | 99,034 | - | 3.3 | 9,403 | Common Stock |
| Biora Therapeutics Inc | Eric d'Esparbes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 62,225 | 90,365 | - | 0 | Common Stock | |
| Biora Therapeutics Inc | Eric d'Esparbes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 22,692 | 113,057 | - | 0 | Common Stock | |
| Biora Therapeutics Inc | Eric d'Esparbes | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.56 per share. | 15 Mar 2023 | 11,216 | 101,841 | - | 2.6 | 28,713 | Common Stock |
| Biora Therapeutics Inc | Eric d'Esparbes | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.46 per share. | 15 Feb 2023 | 269 | 28,140 | - | 3.5 | 931 | Common Stock |
| Biora Therapeutics Inc | Eric d'Esparbes | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jan 2023 | 95 | 0 | - | - | Series X Preferred Stock |